IBM’s stock price rose 2.2% following announcements related to its z17 system entering an agentic AI laboratory environment. The development suggests IBM is advancing its mainframe technology capabilities in the artificial intelligence sector.
IBM’s stock price rose 2.2% following announcements related to its z17 system entering an agentic AI laboratory environment. The development suggests IBM is advancing its mainframe technology capabilities in the artificial intelligence sector.
Sign in to your account